Prime Therapeutics proactive prescriber outreach significantly improves statin use in Medicare members with diabetes
Largest statin use improvement found when program is coupled with proactive pharmacist outreach
News provided by
Share this article
Share this article
EAGAN, Minn., May 11, 2021 /PRNewswire/ Using a proactive prescriber outreach program, Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving nearly 33 million members nationally, saw increased statin use in Medicare members with diabetes. According to the American Diabetes Association, 34.2 million Americans (10.5% of the population) have diabetes.
1 In the Medicare (age 65+) population, the prevalence is even higher at 26.8% of seniors.
1 Statin therapy is recommended for most adults with diabetes based on their cardiovascular risk.